about Iwai Chemicals Company

Iwai Chemicals Co. Ltd. was established in 1947 with the aim of producing and distributing high purity reagents. For the past 70 years we have upheld "integrity" as the cornerstone of our management philosophy, with the understanding that only by earning our customers' trust can we continue to innovate and grow.
Remarkable advances have been made in the field of life science since our founding, especially in the fields of molecular biology, genetic engineering, and immunology. We have achieved its current position as an industry leader by anticipating and acting on the need for specialized reagents in these research areas by compiling a comprehensive product line through partnerships with major manufacturers, both domestic and overseas. Furthermore, in order to meet the various needs of companies, government agencies, universities, and research institutions, we expanded our Technical, Marketing and Planning division, produced our own antibodies, and added numerous services such as large-scale culturing and peptide/DNA synthesis. As the field of life science continues evolving, we continue to evolve as well, constantly endeavoring to discover new areas of potential development, anticipate customers' needs, and stay at the cutting edge of research trends.

In order to provide first-class service, we have continued our efforts to improve our internal supply-line infrastructure. In 1990, we opened a distribution center in Tokyo's Kanda district with the aim of streamlining product management, logistics, and delivery of products to our customers. We subsequently established sales offices in Tsukuba, Tama, Mishima, Yokohama and Kashiwa - all within the Kanto area - in order to provide better service throughout the region. In 2002, we launched a company-wide overhaul of our facilities to significantly enhance IT infrastructure and centralize the sales department at the Kanda 2nd Building. In 2005, our Reagent Technical Support, Equipment/Device Technical Support, and International Purchasing groups were established with the intention of growing and improving our sales support system.

During this time, we have also pursued several external ventures. Iwai USA Inc. was created in 2000 to invest in bio-venture companies around the world. Through Iwai USA Inc., we obtained management rights to Chondrex, Inc., a manufacturer of arthritis and inflammation related reagents. Further expansion into the global market was made in 2006 with the establishment of our international sales office, Iwai North America, Inc. In 2008, Iwai USA Inc. merged out to Iwai North America Inc.

Iwai Chemicals' greatest asset is our employees. We strive to facilitate a work environment in which each person's individuality is respected and valued. We also believe in focusing on training and professional development, aiming to foster future leaders of the reagent industry.

President & CEO: Masao Iwai